Kemula Pierre Thadee Victorinsider trades

In SEC Form 4 filings, Kemula Pierre Thadee Victor is listed as Chief Financial Officer of AgomAb Therapeutics NV (AGMB). In the last 90 days, Kemula Pierre Thadee Victor bought $85.9K of AgomAb Therapeutics NV (AGMB) on the open market and sold none. The largest purchase was $42.9K of AgomAb Therapeutics NV (AGMB) on Oct 6. Took part in a cluster buy; the latest at AgomAb Therapeutics NV (AGMB), where 3 insiders bought within 4 days, ending Oct 8.

Companies and roles

Company	Role	Transactions	Last filed
AGMBAgomAb Therapeutics NV	Chief Financial Officer	3	Oct 7

Cluster buys

AGMB: 3 insiders bought $311.2K between Oct 5 – Oct 8.

Form 4 historysince 2026-10-07

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
AGMBAgomAb Therapeutics NV	Oct 6	Oct 7	P	3,000	$8.67	Purchase +$26,010	3,000	No	Form 4
AGMBAgomAb Therapeutics NV	Oct 6	Oct 7	P	5,000	$8.57	Purchase +$42,850	8,000	No	Form 4
AGMBAgomAb Therapeutics NV	Oct 6	Oct 7	P	2,000	$8.54	Purchase +$17,080	10,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.